Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pain × Analgesics, Opioid × Clear all

Phase

Phase NA 2 Phase 4 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Agnosia 2 Pain 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Hodgkin Disease 1 Breast Neoplasms 1

Interventions

Fentanyl 7 Zoledronic Acid 6 Radiotherapy 6 Morphine 6 Ibandronic Acid 6 nabiximols 5 Ketamine 5 Hydromorphone 5 Analgesia 5 Tapentadol 4 Oxycodone 4 Acetaminophen 4 alvimopan 3 Ropivacaine 3 Prednisone 3 Lidocaine 3 Acupuncture Therapy 3 cabozantinib 2 Tetrodotoxin 2 Mitoxantrone 2 Gabapentin 2 Docetaxel 2 resiniferatoxin 1 oxycodone-acetaminophen 1 oxycodone naloxone combination 1 ixabepilone 1 Triamcinolone Acetonide 1 Triamcinolone 1 Therapeutics 1 Taxes 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00822614 2009-01-14

FINDS

Akela Pharma, Inc.

Phase 3 Unknown

Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡